Committee advances bill to strengthen shield for reproductive and gender‑affirming care after hours of testimony

Senate Bill 25‑129, a measure sponsors said strengthens Colorado’s legal shield for reproductive and gender‑affirming health care, passed out of the Colorado House Judiciary Committee on a 7‑4 vote and was sent to the Committee of the Whole.

The bill’s prime sponsor, Representative Joseph, told the committee the measure updates Colorado law to respond to “a chilling pattern of criminalization, intimidation, and interference” from other states and to keep patients and providers safe. Representative McCormick, a co‑prime sponsor, said the bill clarifies prescription labeling (allowing a practice name to appear on medication labels), requires certain out‑of‑state subpoenas to include sworn statements that they are not intended to criminalize legally protected care, and gives the state attorney general enforcement tools.

Supporters said Colorado already receives patients and providers from states that have restricted care. Dr. Jackson Gonzalez, political director at 1Colorado, told the committee families now travel long distances for care and that relocation assistance requests “jumped from 20 to nearly 600 in a month.” Lauren Smith of Soul to Soul Sisters and Vanessa Martinez of CALOR said the protections are needed to keep providers and patients safe from harassment and legal threats. Several providers, including Shanti Mayer of Boulder Valley Health Center, described growing demand: the clinic reported roughly 500 abortions and almost 200 instances of gender‑affirming care in 2024 and said patient volume has increased in 2025.

Opponents, including multiple physicians and representatives of the Colorado Criminal Defense Bar, argued the bill could insulate providers from accountability and could have unintended consequences. Several physicians warned it might complicate malpractice or informed‑consent enforcement; OB‑GYN Steven Foley said removing provider names from labels could make it harder to hold an individual clinician accountable. Witnesses also objected to an amendment in the draft that would remove certain reporting requirements; Representative Caldwell noted concern about language on page 15 (lines cited in testimony) that would limit the state registrar’s collection or publication of abortion reports.

Committee action and amendments The committee adopted two sponsor amendments before the final committee vote. Amendment L6 removed a section the sponsors said was redundant with existing protections; sponsors described L6 as deleting a section of the bill because section 3 (and prior 2023 law) already provides the intended subpoena protections. Amendment L9 added clarifying language extending the protections to “a person or entity licensed or regulated by the state” and to public entities; sponsors said L9 restored clarity after L6 excised earlier language. Both amendments were adopted in committee before the final vote.

Vote and next steps Representative Carter moved the bill to the Committee of the Whole; on a roll call of committee members the measure passed 7‑4 and will proceed for further consideration. Committee debate focused on privacy and enforcement questions: sponsors and supporters framed the legislation primarily as protecting patient and provider privacy from out‑of‑state subpoenas and harassment, while opponents said the bill risks limiting accountability and public reporting.

Why it matters Sponsors characterized the bill as a response to increased out‑of‑state legal efforts aimed at providers and patients and said the measure builds on Colorado’s 2023 shield law. The bill contains provisions that affect subpoenas, prescription labeling, and the attorney general’s enforcement authority; it also drew scrutiny for language affecting data collection and reporting. The committee record shows competing policy priorities — privacy and cross‑border protection versus preserving pathways for legal accountability and public health reporting — that will shape debate as the bill advances.

What the committee heard Supporters included reproductive‑justice and racial‑justice groups, clinicians and clinic directors who described growing out‑of‑state patient demand and concerns about doxxing and cross‑border legal actions. Opponents included physicians and parents who argued the bill reduced accountability for clinicians and might attract providers who seek legal shelter. Several committee members asked detailed questions about cross‑state subpoena enforcement, liability and informed consent; sponsors said the attorney general would be the enforcement authority under the bill and that the measure carries no fiscal note as drafted.

The bill now moves to the Committee of the Whole for further consideration. The committee record contains extensive witness testimony and the two adopted amendments; the transcript and witnesses’ statements are part of the legislative record.